These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7578647)

  • 41. Cortisol awakening response is elevated in acute coronary syndrome patients with type-D personality.
    Whitehead DL; Perkins-Porras L; Strike PC; Magid K; Steptoe A
    J Psychosom Res; 2007 Apr; 62(4):419-25. PubMed ID: 17383493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypothalamic-pituitary-adrenal axis activity and sleep in posttraumatic stress disorder.
    Otte C; Lenoci M; Metzler T; Yehuda R; Marmar CR; Neylan TC
    Neuropsychopharmacology; 2005 Jun; 30(6):1173-80. PubMed ID: 15714228
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of treatment on plasma cortisol and dexamethasone.
    Carson SW; Halbreich U
    Biol Psychiatry; 1987 Feb; 22(2):213-6. PubMed ID: 3814671
    [No Abstract]   [Full Text] [Related]  

  • 44. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis function.
    Spiegel D; Giese-Davis J; Taylor CB; Kraemer H
    Psychoneuroendocrinology; 2006 Nov; 31(10):1231-44. PubMed ID: 17081700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The dexamethasone suppression test in seasonal affective disorder.
    James SP; Wehr TA; Sack DA; Parry BL; Rogers S; Rosenthal NE
    Compr Psychiatry; 1986; 27(3):224-6. PubMed ID: 3709136
    [No Abstract]   [Full Text] [Related]  

  • 47. Biochemistry and suicidal behavior in depressed patients.
    Secunda SK; Cross CK; Koslow S; Katz MM; Kocsis J; Maas JW; Landis H
    Biol Psychiatry; 1986 Jul; 21(8-9):756-67. PubMed ID: 3730460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined biological tests for suicide prediction.
    Coryell W; Schlesser M
    Psychiatry Res; 2007 Mar; 150(2):187-91. PubMed ID: 17289156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of total sleep deprivation on urinary cortisol, self-rated arousal, and mood in depressed patients.
    Bouhuys AL; Flentge F; Van den Hoofdakker RH
    Psychiatry Res; 1990 Nov; 34(2):149-62. PubMed ID: 2287648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypothalamo-pituitary-adrenal axis dysregulation in patients with rheumatoid arthritis after the dexamethasone/corticotrophin releasing factor test.
    Harbuz MS; Korendowych E; Jessop DS; Crown AL; Li pdfan SL; Kirwan JR
    J Endocrinol; 2003 Jul; 178(1):55-60. PubMed ID: 12844336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Habituation and cortisol dysregulation in depression.
    Reus VI; Peeke HV; Miner C
    Biol Psychiatry; 1985 Sep; 20(9):980-9. PubMed ID: 4027316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.
    Rubin RT; Poland RE; Lesser IM; Winston RA; Blodgett AL
    Arch Gen Psychiatry; 1987 Apr; 44(4):328-36. PubMed ID: 3566455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Endocrinologic testing of alcoholics with depressive states--with special reference to the dexamethasone suppression test].
    Suwa K; Takano K; Nishijima K; Ishiguro T; Enomoto M
    Seishin Shinkeigaku Zasshi; 1983; 85(11):823-6. PubMed ID: 6677920
    [No Abstract]   [Full Text] [Related]  

  • 54. Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy.
    Jenkins PJ; Sohaib SA; Trainer PJ; Lister TA; Besser GM; Reznek R
    Br J Cancer; 1999 Aug; 80(11):1815-9. PubMed ID: 10468302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serial dexamethasone suppression tests in simultaneous panic and depressive disorders.
    Grunhaus L; Flegel P; Haskett RF; Greden JF
    Biol Psychiatry; 1987 Mar; 22(3):332-8. PubMed ID: 3814682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The dexamethasone suppression test in panic disorder and major depressive episodes.
    Faludi G; Kaskó M; Perényi A; Arató M; Frecska E
    Biol Psychiatry; 1986 Sep; 21(11):1008-14. PubMed ID: 3741916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serial dexamethasone suppression tests among rapidly cycling bipolar patients.
    Greden JF; DeVigne JP; Albala AA; Tarika J; Buttenheim M; Eiser A; Carroll BJ
    Biol Psychiatry; 1982 Apr; 17(4):455-62. PubMed ID: 7082711
    [No Abstract]   [Full Text] [Related]  

  • 58. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients.
    Mück-Seler D; Pivac N; Jakovljević M; Brzović Z
    Biol Psychiatry; 1999 Jun; 45(11):1433-9. PubMed ID: 10356625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-occurring manic symptomatology influences HPA axis alterations in depression.
    Jabben N; Nolen WA; Smit JH; Vreeburg SA; Beekman AT; Penninx BW
    J Psychiatr Res; 2011 Sep; 45(9):1208-13. PubMed ID: 21450306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Traumatic childhood background, impulsiveness and hypothalamus-pituitary-adrenal axis dysfunction in eating disorders. A pilot study].
    Basurte E; Díaz-Marsá M; Martín O; Carrasco JL
    Actas Esp Psiquiatr; 2004; 32(3):149-52. PubMed ID: 15168265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.